Coronavirus Update #40\u00a0\u00a0\u00a0 November 30, 2020<\/h2>\n
Cumulative number of reported cases:\u00a0538,883 <\/strong>(as of November 30) <\/strong> Rupiah to US$14,128<\/strong> Testing levels remained static this week with officials seemingly resigned to a relatively low level, even though the capacity is there for a more testing.\u00a0Faced with a 14-day quarantine and the loss of income, many potential subjects \u2013especially daily wage earners\u2014are refraining from getting tested. Central Java governor Ganjar Pranowo stated recently that some regions do not conduct tests to maintain their green zone status. He praised the\u00a0Banyumas administration for tracking down residents with comorbidity factors, such as diabetes or hypertension, in an effort to prevent COVID-19 transmission to those at higher risk from the disease. \u201cPeople [with comorbidities] will be given a bracelet as a sign that they are vulnerable, so that people will avoid close contact,\u201d Ganjar said.<\/p>\n Nationally, active COVID-19 cases are up 8% week-on-week, a 2% increase from the previous week.\u00a0In Jakarta, active cases have plateaued since November 21, according to official figures. \u201cLet us all be more careful because as per Nov. 29, our active case rate has increased to 13.41 percent,\u201d Jokowi said during his opening speech of a Cabinet meeting in Jakarta on Monday.<\/p>\n A national poll revealed that 66% of respondents were willing to participate in a vaccine program. The government will make vaccines freely available to healthcare and other frontline and priority workers. Other recipients will need to pay for the vaccine.<\/p>\n Indonesia\u2019s National Covid-19 Task Force claimed on Saturday (11\/28) that the preparation for the distribution of vaccines against coronavirus is almost complete.<\/p>\n Indonesia has begun talks with officials from US pharmaceutical giant Pfizer to secure the Pfizer-BioNTech Covid-19 vaccine to ensure sufficient supplies before a massive roll-out of a vaccination drive next year in the world’s fourth most populous country. According to officials from BPOM, Indonesia’s Food and Drug Administration, Pfizer offered to help provide the required cold-chain facility to ensure proper distribution of their vaccines.<\/p>\n The following are the current general requirements for traveling to Indonesia:<\/p>\n 1.\u00a0\u00a0 Free Visa\/Visa Exemption and Visa on Arrival\u00a0are temporarily suspended until the COVID-19 pandemic is declared over by the Indonesian Government.<\/p>\n
\nRecovered: 450,518<\/strong>
\nDeaths: 16,945<\/strong>
\n\u00a0<\/strong><\/p>\n![\"\"](\"http:\/\/aiccusa.org\/wp-content\/uploads\/2021\/01\/covid-nov-30-1024x711.png\")
<\/p>\n
\nJakarta Stock Exchange Index: 5612<\/strong><\/p>\nOverview- Active Cases Up<\/strong><\/h3>\n
Travel <\/strong><\/h3>\n